Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study.
BMJ Neurol Open. 2022 Nov 4;4(2):e000334. doi: 10.1136/bmjno-2022-000334. eCollection 2022.
BMJ Neurol Open. 2022.
PMID: 36353267
Free PMC article.